Maxwell V. Meng, MD received his undergraduate training from Harvard College, where he obtained his degree in biochemical sciences magna cum laude. He then attended the Johns Hopkins School of Medicine where he was inducted into the Alpha Omega Alpha honor society. Dr. Meng obtained his general surgery and urology training at the University of California San Francisco. Subsequently, he combined his interest in urologic oncology and minimally invasive surgery, completing fellowships in both under the guidance of Peter Carroll, MD, MPH and Marshall Stoller, MD. Upon completion of his fellowships Dr. Meng has continued as UCSF faculty (Professor) specializing in urologic cancers and laparoscopy. He is part of the multidisciplinary urologic oncology team of the UCSF Comprehensive Cancer Center located at Mission Bay. He also operates at the San Francisco Veterans Affairs Medical Center and San Francisco General Hospital. Dr. Meng's clinical interests include the diagnosis and management of genitourinary malignancy, and minimally invasive treatment of benign and malignant diseases. He has experience with robotic surgery and is actively involved in the development of new technologies. Dr. Meng is an active member of the American Urological Association (AUA), an active member of the Western Section of the AUA, and a member of the American College of Surgeons. Dr. Meng teaches laparoscopic techniques at the UCSF Urologic Laparoscopy course, and he has moderated the laparoscopy session at the Western Section of the AUA. Dr. Meng has written over 140 peer-reviewed publications and 9 chapters covering many aspects of oncology, minimally invasive surgery, and renal trauma. In particular, his current research interests include novel molecular therapeutics in bladder cancer, molecular predictors of prostate cancer, and minimally invasive approaches to urologic cancer.